Results 141 to 150 of about 28,133 (254)

Evidence for Electrocardiographic Patterns Identifying Acute Coronary Occlusion in Non‐ST‐Elevation Acute Coronary Syndromes: A Scoping Review

Academic Emergency Medicine, Volume 33, Issue 8, August 2026.
ABSTRACT Background Approximately one‐quarter to one‐third of patients with non‐ST‐elevation myocardial infarction have a completely occluded culprit coronary artery but are not routinely referred for emergent reperfusion. A growing literature describes electrocardiographic patterns purported to identify acute coronary occlusion (ACO) in non‐STEMI ...
Andrew P. Grimes, Sonja J. Maria
wiley   +1 more source

From GUSTO to TIMI to BARC

Interventional cardiologists have long navigated the balance between ischemic and bleeding risks in patients with coronary artery disease, from the dawn of thrombolysis therapy to today’s drug-eluting stent era. Historically, bleeding events were not systemically reported in clinical trials, leading to varied reported incidences.
Tsai, Tsung-Ying, Renkens, Mick, Wang, Bo, Onuma, Yoshinobu, Serruys, Patrick W., Garg, Scot, Capodanno, Davide, Angiolillo, Dominick J.   +7 more
openaire   +2 more sources

Cost‐Effectiveness of NT‐proBNP–Guided Cardiovascular Screening in Chinese Adults With Type 2 Diabetes: Real‐World Evidence From the Hong Kong Diabetes Biobank

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7342-7351, August 2026.
ABSTRACT Aims Heart failure (HF) is among the most costly and prevalent complications of type 2 diabetes (T2D), with annual incremental healthcare costs reaching US$12800 in Hong Kong. We evaluated the cost‐effectiveness of NT‐proBNP‐guided cardiovascular risk stratification to guide cardioprotective treatment. Materials and Methods We developed a four‐
Abby Q. Y. Li, Benjamin Yarnoff, Claudia H. T. Tam, Juliana C. N. Chan, Ronald C. W. Ma, Juliana N. M. Lui, Hong Kong Diabetes Biobank Study Group   +6 more
wiley   +1 more source

Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF‐TIMI 48 Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Epistaxis is common with antithrombotic therapy and is often troublesome to patients, yet its frequency, severity, and outcomes are poorly characterized.
Robert S. Semco, Regan W. Bergmark, Sabina A. Murphy, Abby L. Cange, Martin Unverdorben, Cathy Z. L. Chen, Christian T. Ruff, Elliott M. Antman, Robert P. Giugliano, Brian A. Bergmark   +9 more
doaj   +1 more source

Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D‐PATH study)

Journal of Diabetes Investigation, Volume 17, Issue 8, Page 1322-1334, August 2026.
Graphical abstract illustrating the study design, physiological rationale, and key findings of the D‐PATH trial. Dapagliflozin, an SGLT2 inhibitor, lowers HbA1c and body weight while increasing hematocrit and erythropoietin levels. Although an elevated hematocrit could theoretically increase blood viscosity and impair microcirculatory flow, ex vivo ...
Yuki Nakatani, Nobuyuki Banba, Shoya Ono, Tomoki Turumi, Megumi Hoshiai, Takushi Sugiyama, Takashi Tomoe, Hajime Tamiya, Naoyuki Otani, Hiroyuki Sugimura, Hidekazu Ikemiyagi, Yusuke Ohya, Koji Yokokawa, Shinichiro Ueda, Yoshimasa Aso, Yasuhiro Maejima, Takanori Yasu   +16 more
wiley   +1 more source

Editorial on PEGASUS — TIMI 54

International Journal of Cardiology, 2016
Trantalis, G., Katsi, V., Toutouzas, K., Tousoulis, D.   +3 more
openaire   +3 more sources

The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities

Journal of Internal Medicine, Volume 300, Issue 2, Page 131-152, August 2026.
Abstract Type 2 diabetes (T2D) is a major global health concern strongly associated with atherosclerosis and subsequent macrovascular complications. These complications are the leading cause of death among T2D patients. Despite a decline in cardiovascular events over the last decade, individuals with T2D still have an approximately doubled risk ...
Dania Al‐Sharify, Jiangming Sun, Andreas Edsfeldt   +2 more
wiley   +1 more source

Application of the TIMI risk score in ED patients with cocaine-associated chest pain. [PDF]

, 2007
OBJECTIVE: The TIMI risk score has been validated as a risk stratification tool in emergency department (ED) patients with potential acute coronary syndrome.
Zogby, Kara E, Chmielewski, Lauren, Robey, Jennifer L, Chase, Maureen, Brown, Aaron M, Hollander, Judd E, Shofer, Frances S   +6 more
core